A new AI-powered risk prediction model assists clinicians in treating cancer patients following a heart attack by combining oncology and cardiovascular data.
Key Details
- 1Researchers at University of Zurich developed ONCO-ACS, an AI-based tool for individualized risk assessment in cancer patients post-heart attack.
- 2Used data from over 1 million heart attack patients, including 47,000 with cancer, from England, Sweden, and Switzerland.
- 3Cancer patients showed a nearly 1 in 3 mortality rate within six months after a heart attack.
- 4ONCO-ACS predicts risks of death, major bleeding, or recurrent cardiac event within six months, using both cancer-related and standard cardiovascular data.
- 5The tool is validated and aims to support tailored decisions regarding catheter-based interventions and antiplatelet therapy.
Why It Matters
This is among the first AI tools designed specifically for the intersection of oncology and cardiology, addressing a major gap in risk prediction for a previously overlooked patient population. It could improve outcomes and inform personalized care strategies in radiology and broader clinical management.
Source
EurekAlert
Related News
•EurekAlert
AI-Powered OCT Enables Rapid 'Optical Biopsy' for Early Endometrial Cancer Detection
A team at Washington University has developed a catheter-based 3D OCT system with AI to quickly and noninvasively detect early endometrial cancers.
•EurekAlert
AI Clinical Reasoning in Diagnostics and Digital Fatigue in Healthcare
Recent JMIR features explore large language models in clinical diagnostics and digital fatigue among healthcare professionals.
•EurekAlert
KAIST, MIT, Microsoft Develop Efficient AI Image Upsampling for Robotics
KAIST, MIT, and Microsoft have created 'Upsample Anything,' a training-free AI method to restore high-resolution visual data from compressed images with up to 16x improved GPU memory efficiency.